Electrovac (EVAC) investor relations material

Executive summary

• Revenue increased by 20.2% year-over-year to EUR 118.0 million, surpassing internal forecasts by 9.8%.

• EBIT rose to EUR 14.0 million from EUR 9.1 million, with the EBIT margin improving to 11.9% from 9.3%.

• Net income nearly doubled to EUR 9.6 million, and EPS increased to EUR 0.79 from EUR 0.43.

• The company completed a successful IPO on April 30, 2026, raising gross proceeds of EUR 30 million to fund global expansion.

Financial highlights

• Operating cash flow was EUR 10.2 million, up from EUR 9.4 million year-over-year.

• Cash flow from investing activities was EUR -3.8 million, reflecting continued investment in capacity expansion.

• Equity increased to EUR 51.7 million, with an equity ratio of 55.1%.

• Total assets rose to EUR 93.8 million, and cash and cash equivalents reached EUR 2.1 million.

• Dividend of EUR 2.35 million was paid, partially offset against shareholder loans.

Outlook and guidance

• Revenue for 2026/2027 is projected between EUR 120–130 million, with EBIT expected at EUR 11–12 million (including EUR 2.3 million IPO costs).

• Medium-term targets are revenue above EUR 150 million and an EBIT margin exceeding 12%.

• Expansion plans include doubling Thai production space, establishing final assembly in China, and entering the US defense market.

• Book-to-bill ratio in Q1 2026/2027 was 2.3, indicating strong order momentum.